Fig. 5From: The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degenerationOCTA imaging of a mixed type 1, type 3 MNV before treatment that regressed within 18 months of follow up with 4 injections of anti-VEGF. a–c baseline OCTA imaging from the RTVue XR Avanti device. a En face image of the outer retinal slab showing flow that corresponds to the type 3 MNV component of the MNV (yellow arrow). b Corresponding B-scan through the lesion with flow signal. c Corresponding B-scan through the lesion showing outer retinal slab segmentation lines. d–f Endpoint OCTA imaging from the RTVue XR Avanti device. d En face image of the choriocapillaris after 18 months of follow-up. Cyan line denotes the cross-sectional location through which the B-scan was derived. e Corresponding B-scan through the region of atrophy revealing no intraretinal or sub-RPE flow signal. f Corresponding B-scan through the region of atrophy showing the choriocapillaris segmentation linesBack to article page